OTLC — Oncotelic Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Oncotelic Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.569	0.241	0.17	0.086	0.089
Net Total Accounts Receivable
Net Total Receivables	0.02	0.02	0.019	0.019	0.051
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.627	0.303	0.272	0.134	1.2
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	—	—	—	—
Net Goodwill
Net Intangible Assets
Long Term Investments
Total Assets	23.6	36.1	30	26.7	393
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15.5	16.9	16.5	19.2	18.1
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Liabilities	15.7	16.7	17.9	18.4	130
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	7.96	19.4	12.1	8.25	263
Total Liabilities & Shareholders' Equity	23.6	36.1	30	26.7	393
Total Common Shares Outstanding
Total Preferred Shares Outstanding